Market Overview

Juno Therapeutics Surges Another 5%, Breaks Above $50 level

Related JUNO
Attention Biotech Investors: February PDUFA Catalysts Come Calling
Gilead Sciences Outlook Brightens; Citi Upgrades
Biotechs: Still Well Placed For More Gains (Seeking Alpha)

Shares of Juno Therapeutics Inc (NASDAQ: JUNO) began trading on December 19 with an IPO price of $24 per share. Following the IPO, the stock was volatile but remained below $40 per share in its first four trading sessions.

The stock on Friday broke out above the $40 level and closed up over 22 percent. The momentum carried over into Monday’s pre-market as shares recently traded at $51.19, up 5.17 percent.

Monday’s surge above $50 came amid the company’s 8-K filing, which stated that it acquired Opus Bio for $20 million in cash and issued to Opus Bio 1.6 million shares of common stock.

Posted-In: Long Ideas News Short Ideas Movers Trading Ideas


Related Articles (JUNO)

View Comments and Join the Discussion!